Science Pool

Evotec achieves milestone in its neurodegeneration collaboration with Bristol Myers Squibb

Evotec SE announced today that the Company has received a US$ 6 m payment from Bristol Myers Squibb Company (NYSE:BMY) within the companies’ iPSC-based neuroscience partnership. The payment follows Bristol Myers Squibb’s decision to add another drug discovery project to the partnership’s portfolio.
Read More

Twitter
LinkedIn
Email
Generated by Feedzy